Provides high-quality 3D imaging at 2D low-radiation doses
The Christine E. Lynn Women’s Health & Wellness Institute at
Boca Raton Regional Hospital is the first in Florida to offer SenoClaire™
three-dimensional breast tomosynthesis by GE Healthcare. The versatile
imaging technology provides mammograms with high resolution, low radiation
and excellent detection for patients with all types of breast tissues,
resulting in a more confident screening.
While other programs moved quickly to introduce first-generation technology,
the Hospital waited until it could provide its patients with the latest
in digital breast tomosynthesis. SenoClaire™ is the only 3D breast
tomosynthesis approved by the U.S. Food and Drug Administration that delivers
the same low dose as 2D screenings, with a 3D view dose at least 40 percent
lower than other 3D mammography on the market.*
SenoClaire™ is also the only FDA-approved digital breast tomosynthesis
to use a “step-and-shoot” method, a short X-ray sweep around
the positioned breast, to acquire exposures. Since the tube comes to a
complete stop when capturing each one of the nine exposures, this technique
removes potential motion from the tube and helps reduce blur and increase
image sharpness.
Moreover, the SenoClaire™ imaging technique separates tissues and
reduces overlapping of structures, enabling better characterization of
malignant and benign findings compared with traditional mammography. Our
physicians believe that using 3D mammography can help improve cancer detection
in patients with dense breasts. Common among women, dense breasts have
more fibrous or glandular tissue versus fatty tissue. Though cancer is
more likely to develop in dense breasts, 2D mammography may not always
accurately detect it.
“We are pleased to bring our patients the latest in 3D mammography,
advancing our ability to provide women with a more personalized and precise
screening process,” said Kathy Schilling, MD, Medical Director of
the Lynn Women’s Health & Wellness Institute. “As we know,
there is a better rate of survival when cancer is discovered and treated
early. This technology marks another significant step forward in enhancing
our clinicians’ ability to detect masses and small microcalcifications,
which can represent cancer at its most curable stage.”
*Leuven University: Application of the draft EUREF protocol for Quality
Control of digital breast tomosynthesis (DBT) systems, Marshall &
Bosmans (February 2014)
About Boca Raton Regional Hospital – Advancing the boundaries of medicine.
Boca Raton Regional Hospital is an advanced, tertiary medical center (BRRH.com) with 400 beds and more than 800 primary and specialty physicians on staff.
The Hospital is a recognized leader in oncology, cardiovascular disease
and surgery, minimally invasive surgery, orthopedics, women’s health,
emergency medicine and the neurosciences, all of which offer state-of-the-art
diagnostic and imaging capabilities. The Hospital is a designated Comprehensive
Stroke Center by the Florida Agency for Health Care Administration (AHCA).
Boca Raton Regional Hospital is the recipient of the 2014 Distinguished
Hospital Award for Clinical Excellence™ for the 10th year in a row
and was named one of America’s 50 Best Hospitals in 2011, 2012,
2013 and 2014, both by Healthgrades®. Boca Raton Regional Hospital
was also recognized for the third consecutive year in U.S. News &
World Report’s 2013–2014 Best Hospitals listing as a top-ranked
hospital in the South Florida metropolitan area.
Media Contact:
Thomas Chakurda, 561.955.3586
Vice President, Marketing
tchakurda@brrh.com